Zyprexa is frequently in the headlines of many media organizations, but it is doubtful Eli Lilly & Co desires the types of publicity their product receives. Numerous individual and class action lawsuits in recent months have cast new light on the dangers Zyprexa poses to uninformed patients. As media outlets focus more and more on the cases of diabetes, stroke, and obesity caused by Zyprexa, those who prescribe and take the drug have a greater knowledge of the risks it poses which could possibly save lives. In addition to being lambasted in print and on the internet, Zyprexa has been the news topic of numerous radio and television talk shows, and continues to fuel nationwide debate on the role negligence and responsibility of pharmaceutical companies worldwide.
Click on the links below to read recent news articles about Zyprexa:
Discovery Limited In Zyprexa Case